Loading...
Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples
INTRODUCTION –: ROS1 gene fusions are a well-characterized class of oncogenic driver found in approximately 1-2% of non-small cell lung cancer patients. ROS1-directed therapy in these patients is more efficacious and is associated with fewer side effects compared to chemotherapy and is thus now cons...
Na minha lista:
| Udgivet i: | J Thorac Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286810/ https://ncbi.nlm.nih.gov/pubmed/29935306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2018.05.041 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|